Skip to content

Clinical trials

Phase 3 Virus Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Virus Diseases Phase: Phase 3 Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20133
20171
20181
20191
20207
20218
20222
20235
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting4
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.11
National Institute of Allergy and Infectious Diseases (NIAID)10
Gilead Sciences3
BioNTech SE2
Medicago2
National Center for Research Resources (NCRR)2
Pfizer2
Adrian Hernandez1
AstraZeneca1
Biotest Pharmaceuticals Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases39
Coronavirus Infections21
COVID-1920
RNA Virus Infections20
Coronaviridae Infections14
Nidovirales Infections13
Severe Acute Respiratory Syndrome12
Respiratory Tract Infections8
Infections6
Influenza, Human6

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.